Boston Scientific Corp (BSX)

41.40
+0.70(+1.72%)
After Hours
41.38
-0.02(-0.05%)
- Real-time Data
  • Volume:
    7,368,469
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    41.05 - 42.06

BSX Overview

Prev. Close
40.7
Day's Range
41.05-42.06
Revenue
11.47B
Open
41.1
52 wk Range
33.42-46.28
EPS
0.77
Volume
7,368,469
Market Cap
58.99B
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
7,099,104
P/E Ratio
53.91
Beta
0.87
1-Year Change
20.88%
Shares Outstanding
1,424,992,477
Next Earnings Date
Feb 03, 2022
What is your sentiment on Boston Scientific Corp?
or
Market is currently closed. Voting is open during market hours.

Boston Scientific Corp Company Profile

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; percutaneous coronary interventions products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as various peripheral vessels; and structural heart therapies. Further, it provides stents, balloon catheters, wires, atherectomy systems to treat arterial diseases; thrombectomy and acoustic pulse thrombolysis systems, wires, and stents to treat venous diseases; and peripheral embolization devices, radioactive microspheres, ablation systems, and micro and drainage catheters to treat cancer. The company was founded in 1979 and is headquartered in Marlborough, Massachusetts.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellNeutralBuyNeutralBuy
Technical IndicatorsStrong SellStrong SellStrong BuyNeutralBuy
SummaryStrong SellSellStrong BuyNeutralBuy
  • showing cup handle pattern on multiyr time frame..about to break out big!
    0
    • opens with bullish gap every day. but sellers rush!?
      0
      • going to 37.5
        2
        • Call for today
          1
          Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
          Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.